CoChat
Sign Up
Cited by 155

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Curcumin Improves Amyloid β-Peptide (1-42) Induced Spatial Memory Deficits through BDNF-ERK Signaling Pathway

Zhang, Lu, Fang, Yu, Xu, Yuming, Lian, Yajun, Xie, Nanchang, Wu, Tianwen, Zhang, Haifeng, Sun, Limin, Zhang, Ruifang, Wang, Zhenhua·2015·PLOS ONE
DOI 10.1371/journal.pone.0131525PMC PMC4482657
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0131525

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ERK signaling has been linked to the cognitive-enhancing effects of plant secondary metabolites, such as curcumin and apigenin.

    “Along these lines, it is intriguing that ERK signaling has been linked to the cognitive-enhancing effects of plant secondary metabolites, such as curcumin and apigenin.46,47”

    From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [46]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 42

  1. DJ Selkoe, 1991, The molecular pathology of Alzheimer's disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2 · DOI · Paper page
  2. XY Qin, 2010, Potential protection of curcumin against intracellular amyloid beta-induced toxicity in cultured rat prefrontal cortical neurons, Neuroscience letters, 480, 21, 10.1016/j.neulet.2010.05.062 · DOI
  3. J Ye, 2012, Curcumin protects against intracellular amyloid toxicity in rat primary neurons, International journal of clinical and experimental medicine, 5, 44
  4. GP Lim, 2001, The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse, The Journal of neuroscience: the official journal of the Society for Neuroscience, 21, 8370, 10.1523/JNEUROSCI.21-21-08370.2001 · DOI · Paper page
  5. AN Begum, 2008, Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease, The Journal of pharmacology and experimental therapeutics, 326, 196, 10.1124/jpet.108.137455 · DOI · Paper page
  6. CY Sun, 2013, Neurobiological and pharmacological validity of curcumin in ameliorating memory performance of senescence-accelerated mice, Pharmacology, biochemistry, and behavior, 105, 76, 10.1016/j.pbb.2013.02.002 · DOI · Paper page
  7. Y Xu, 2009, Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress, Neuropharmacology, 57, 463, 10.1016/j.neuropharm.2009.06.010 · DOI · Paper page
  8. JB Hoppe, 2013, Curcumin protects organotypic hippocampal slice cultures from Abeta1-42-induced synaptic toxicity, Toxicology in vitro: an international journal published in association with BIBRA, 27, 2325, 10.1016/j.tiv.2013.10.002 · DOI
  9. JB Hoppe, 2013, Free and nanoencapsulated curcumin suppress beta-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3beta signaling pathway, Neurobiology of learning and memory, 106, 134, 10.1016/j.nlm.2013.08.001 · DOI
  10. YA Barde, 1987, Brain derived neurotrophic factor, Progress in brain research, 71, 185, 10.1016/S0079-6123(08)61823-3 · DOI
  11. J Leibrock, 1989, Molecular cloning and expression of brain-derived neurotrophic factor, Nature, 341, 149, 10.1038/341149a0 · DOI
  12. RS Duman, 2000, Neuronal plasticity and survival in mood disorders, Biological psychiatry, 48, 732, 10.1016/S0006-3223(00)00935-5 · DOI · Paper page
  13. CW Cotman, 2002, Exercise: a behavioral intervention to enhance brain health and plasticity, Trends in neurosciences, 25, 295, 10.1016/S0166-2236(02)02143-4 · DOI · Paper page
  14. B Connor, 1998, The role of neuronal growth factors in neurodegenerative disorders of the human brain, Brain research Brain research reviews, 27, 1, 10.1016/S0165-0173(98)00004-6 · DOI
  15. MG Murer, 2001, Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease, Progress in neurobiology, 63, 71, 10.1016/S0301-0082(00)00014-9 · DOI · Paper page
  16. P Davies, 1976, Selective loss of central cholinergic neurons in Alzheimer's disease, Lancet, 2, 1403, 10.1016/S0140-6736(76)91936-X · DOI · Paper page
  17. C Laske, 2011, Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients, The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum, 14, 399, 10.1017/S1461145710001008 · DOI · Paper page
  18. M Typlt, 2013, Mice with deficient BK channel function show impaired prepulse inhibition and spatial learning, but normal working and spatial reference memory, PloS one, 8, e81270, 10.1371/journal.pone.0081270 · DOI
  19. K Yamada, 1999, Improvement by nefiracetam of beta-amyloid-(1–42)-induced learning and memory impairments in rats, British journal of pharmacology, 126, 235, 10.1038/sj.bjp.0702309 · DOI
  20. S Nakamura, 2001, Progressive brain dysfunction following intracerebroventricular infusion of beta(1–42)-amyloid peptide, Brain research, 912, 128, 10.1016/S0006-8993(01)02704-4 · DOI
  21. Y Wang, 2011, Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease, Neuroscience letters, 487, 70, 10.1016/j.neulet.2010.09.076 · DOI
  22. X Zhu, 2012, Diammonium glycyrrhizinate upregulates PGC-1alpha and protects against Abeta1-42-induced neurotoxicity, PloS one, 7, e35823, 10.1371/journal.pone.0035823 · DOI
  23. I Ferrer, 1999, BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies, Journal of neuropathology and experimental neurology, 58, 729, 10.1097/00005072-199907000-00007 · DOI
  24. C Hock, 2000, Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas, Archives of neurology, 57, 846, 10.1001/archneur.57.6.846 · DOI · Paper page
  25. J Lee, 2005, Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms, Experimental neurology, 194, 91, 10.1016/j.expneurol.2005.01.026 · DOI
  26. S Peng, 2005, Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease, Journal of neurochemistry, 93, 1412, 10.1111/j.1471-4159.2005.03135.x · DOI · Paper page
  27. C Laske, 2007, BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls, Journal of psychiatric research, 41, 387, 10.1016/j.jpsychires.2006.01.014 · DOI · Paper page
  28. W Fischer, 1994, Reversal of spatial memory impairments in aged rats by nerve growth factor and neurotrophins 3 and 4/5 but not by brain-derived neurotrophic factor, Proceedings of the National Academy of Sciences of the United States of America, 91, 8607, 10.1073/pnas.91.18.8607 · DOI
  29. MA Pelleymounter, 1996, The effects of intrahippocampal BDNF and NGF on spatial learning in aged Long Evans rats, Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid, 29, 211
  30. SD Croll, 1999, Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex, Neuroscience, 93, 1491, 10.1016/S0306-4522(99)00296-1 · DOI
  31. H Kang, 1995, Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus, Science, 267, 1658, 10.1126/science.7886457 · DOI · Paper page
  32. JD Sweatt, 2004, Mitogen-activated protein kinases in synaptic plasticity and memory, Current opinion in neurobiology, 14, 311, 10.1016/j.conb.2004.04.001 · DOI
  33. B Webster, 2006, Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease, Journal of neuropathology and experimental neurology, 65, 142, 10.1097/01.jnen.0000199599.63204.6f · DOI
  34. KT Dineley, 2001, Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease, The Journal of neuroscience: the official journal of the Society for Neuroscience, 21, 4125, 10.1523/JNEUROSCI.21-12-04125.2001 · DOI · Paper page
  35. G Amadoro, 2006, NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation, Proceedings of the National Academy of Sciences of the United States of America, 103, 2892, 10.1073/pnas.0511065103 · DOI · Paper page
  36. BT Hyman, 1994, Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease, The American journal of pathology, 144, 565
  37. L Zhang, 2012, Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice, Behavioural brain research, 235, 67, 10.1016/j.bbr.2012.07.019 · DOI
  38. R Wang, 2010, Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons, Progress in neuro-psychopharmacology & biological psychiatry, 34, 147, 10.1016/j.pnpbp.2009.10.016 · DOI
  39. L Tong, 2004, Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons, The Journal of neuroscience: the official journal of the Society for Neuroscience, 24, 6799, 10.1523/JNEUROSCI.5463-03.2004 · DOI · Paper page
  40. X Xu, 2007, Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender, Genome biology, 8, R234, 10.1186/gb-2007-8-11-r234 · DOI
  41. M Llorens-Martin, 2014, GSK-3beta, a pivotal kinase in Alzheimer disease, Frontiers in molecular neuroscience, 7, 46
  42. B DaRocha-Souto, 2012, Activation of glycogen synthase kinase-3 beta mediates beta-amyloid induced neuritic damage in Alzheimer's disease, Neurobiology of disease, 45, 425, 10.1016/j.nbd.2011.09.002 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Zhang, L., Fang, Y., Xu, Y., Lian, Y., Xie, N., Wu, T., Zhang, H., Sun, L., Zhang, R., & Wang, Z.
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2015-06-26
Volume
10
Issue
6
Pages
e0131525
ISSN
1932-6203
DOI
10.1371/journal.pone.0131525
PMC
PMC4482657
Cited by
155
References
7
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review